Please provide your email address to receive an email when new articles are posted on . More than 13% of users of quetiapine and haloperidol developed severe QT prolongation. Severe QT prolongation ...
December 7, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for quetiapine fumarate extended-release tablets (Seroquel XR, AstraZeneca Pharmaceuticals, LP), allowing ...
The use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation, ...
Overprescribing warning letters modestly cut the use of antipsychotic medications without apparent repercussion in people with dementia, a secondary analysis of a randomized trial indicated. Compared ...
Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...
PHILADELPHIA — Pimavanserin (Nuplazid) is noninferior to quetiapine in patients with Parkinson's disease (PD) psychosis at 56 days, results from a phase 3 trial showed. In the first prospective ...
WILMINGTON, Del. An advisory committee of the Food and Drug Administration has given a mixed review to an approval application by AstraZeneca seeking additional uses for one of its drugs as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback